These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 6307558)
1. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4. Moqbel R; Sass-Kuhn SP; Goetzl EJ; Kay AB Clin Exp Immunol; 1983 Jun; 52(3):519-27. PubMed ID: 6307558 [TBL] [Abstract][Full Text] [Related]
2. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Nagy L; Lee TH; Goetzl EJ; Pickett WC; Kay AB Clin Exp Immunol; 1982 Mar; 47(3):541-7. PubMed ID: 6282507 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro. Moqbel R; MacDonald AJ; Kay AB Clin Exp Immunol; 1985 Mar; 59(3):577-86. PubMed ID: 3987093 [TBL] [Abstract][Full Text] [Related]
4. Enhanced granulocyte cytotoxicity by mediators derived from anti-IgE-stimulated human leucocytes. Moqbel R; MacDonald AJ; Kay AB Immunology; 1986 Sep; 59(1):87-93. PubMed ID: 2428736 [TBL] [Abstract][Full Text] [Related]
5. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni. Moqbel R; Macdonald AJ; Cromwell O; Kay AB Immunology; 1990 Mar; 69(3):435-42. PubMed ID: 2312166 [TBL] [Abstract][Full Text] [Related]
6. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides. Anwar AR; McKean JR; Smithers SR; Kay AB J Immunol; 1980 Mar; 124(3):1122-9. PubMed ID: 7358978 [No Abstract] [Full Text] [Related]
7. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid. Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846 [TBL] [Abstract][Full Text] [Related]
8. Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro. Hamada A; Greene BM J Immunol; 1987 Feb; 138(4):1240-5. PubMed ID: 3492545 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of the expression of eosinophil IgE receptor (Fc epsilon R2) and its function by platelet-activating factor. Walsh GM; Moqbel R; Nagakura T; Iikura Y; Kay AB J Lipid Mediat; 1990; 2 Suppl():S177-86. PubMed ID: 1966815 [TBL] [Abstract][Full Text] [Related]
10. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils. Moser G; Sher A J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624 [TBL] [Abstract][Full Text] [Related]
11. Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity. Moqbel R; Richerson HB; MacDonald AJ; Walsh GM; Hartnell A; Walport MJ; Kay AB Clin Exp Immunol; 1987 Sep; 69(3):676-86. PubMed ID: 2959415 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. Silberstein DS; Owen WF; Gasson JC; DiPersio JF; Golde DW; Bina JC; Soberman R; Austen KF; David JR J Immunol; 1986 Nov; 137(10):3290-4. PubMed ID: 3095427 [TBL] [Abstract][Full Text] [Related]
13. Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils. Kay AB; Walsh GM Clin Exp Immunol; 1984 Sep; 57(3):729-34. PubMed ID: 6088141 [TBL] [Abstract][Full Text] [Related]
14. Preferential generation of leukotriene C4 by human eosinophils. Shaw RJ; Cromwell O; Kay AB Clin Exp Immunol; 1984 Jun; 56(3):716-22. PubMed ID: 6086189 [TBL] [Abstract][Full Text] [Related]
15. Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187. Dessein AJ; Lee TH; Elsas P; Ravalese J; Silberstein D; David JR; Austen KF; Lewis RA J Immunol; 1986 May; 136(10):3829-38. PubMed ID: 3009610 [TBL] [Abstract][Full Text] [Related]
16. Eosinophil-mediated killing of schistosomula of Schistosoma mansoni in vitro: synergistic effect of antibody and complement. McLaren DJ; Ramalho-Pinto FJ J Immunol; 1979 Oct; 123(4):1431-8. PubMed ID: 479590 [No Abstract] [Full Text] [Related]
17. [The kinetics of cell-mediated cytotoxicity to schistosomula of Schistosoma japonicum with sera from infected mice at different duration]. Tao YW; Lui SX Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(3):182-5. PubMed ID: 1959170 [TBL] [Abstract][Full Text] [Related]
18. Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes. Capron M; Kazatchkine MD; Fischer E; Joseph M; Butterworth AE; Kusnierz JP; Prin L; Papin JP; Capron A J Immunol; 1987 Sep; 139(6):2059-65. PubMed ID: 2957447 [TBL] [Abstract][Full Text] [Related]
20. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils. Anwar AR; Smithers SR; Kay AB J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435 [No Abstract] [Full Text] [Related] [Next] [New Search]